Early detection of cancer

Montserrat Garcia Martinez

PRINCIPAL INVESTIGATORS
  • Gemma Binefa Rodríguez
  • Carmen Vidal Lancis
  • Noémie Travier
CLINICAL RESEARCHERS
  • Raúl Ortega Martínez
  • Anna Gumà Martínez
POSTDOCTORAL RESEARCHERS
  • Ena Pery Niño De Guzman Quispe
PREDOCTORAL RESEARCHERS
  • Nuria Vives Martin
  • Roberto Martín Vaello
  • María Vicente Quílez
SCIENTIFIC SUPPORT
  • Rafael Muñoz Castro
  • Berta Casas Lopez
  • Yolanda Valverde Alcántara
  • Laura Sanchez Vazquez
  • Jon Aritz Panera Carracedo
MANAGEMENT SUPPORT
  • Virtudes Guardiola Gomez
  • Marcos Castejon Suñer
  • Nuria Quirós Vallejo
Cancer
EPIBELL

Scientific production

8

PAPERS

Average IF: 3,48

5

LED PAPERS

Average IF: 3,54

5 PUBLICATIONS IN FIRST QUARTILE

8 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Steinberg,J;Hughes,S;Hui,HR;Allsop,MJ;Egger,S;David,M;Caruana,M et al, Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis, Int. J. Cancer, 2024;154(8):1394-1412, doi:10.1002/ijc.34798
  • Falo,C;Azcarate,J;Fernandez Gonzalez,S;Perez,X;Petit,A;Perez,H;Vethencourt,A et al, Breast Cancer Patient’s Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease, Cancers, 2024;16(13):doi:10.3390/cancers16132421
  • Fullana,B;Morales,S;Petit,A;Alay,A;Verdaguer,H;Climent,F;Navarro Perez,V et al, Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial., Sci Rep, 2024;14(1):23626-23626, doi:10.1038/s41598-024-72152-1
  • Vives,N;Travier,N;Farre,A;Binefa,G;Vidal,C;Lacasta,MJP;Ibáñez Sanz,G et al, Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study), JMIR Public Health Surveill., 2024;10doi:10.2196/57959
  • Fernandez Gonzalez,S;Falo,C;Pla,MJ;Campos,M;Ortega Exposito,C;Ortega,R;Vicente,M et al, Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival-a propensity score cohort study, Breast Cancer Res Treat, 2024;206(1):131-141, doi:10.1007/s10549-024-07274-1

Research highlights

PROJECTS

3 Ongoing competitive projects

NETWORKS

GRC SGR 1283
CCGMC
ICSN
ECICC
ECIBC
WEO

Selected projects

  • 2022-C23.I01.P03.S0020-0000209_19. INVESTIGO 2022. SERVICIO PUBLICO DE EMPLEO ESTATAL SEPE. Budget: 66.217,68€. 2023-2024. PI: García Martínez, Montserrat.
  • PI22/01015. Implementación de estrategias mediante SMS para recuperar adherencia en programas poblacionales de cribado de cáncer (estudio M-TICS 2). Instituto de Salud Carlos III (ISCIII). Budget: 50.820€. 2023-2025. PI: García Martínez, Montserrat.
  • PI19/00226. Implementación de la mensajería de texto (SMS) como herramienta de mejora en los programas poblacionales de cribado de cáncer. Instituto de Salud Carlos III (ISCIII). Budget: 38.720€. 2020-2024. PI: García Martínez, Montserrat.